Talking Points
By TCTMD
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by TCTMD
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 177
Description
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
| Episode | Date |
|---|---|
|
The REDUCE-AMI Trial
|
May 07, 2025 |
|
The EARTH-STEMI Trial
|
Apr 16, 2025 |
|
The SCOFF Trial
|
Apr 09, 2025 |
|
The RESHAPE-HF2 and MATTERHORN Trials
|
Apr 02, 2025 |
|
The EMPACT-MI Trial
|
Mar 19, 2025 |
|
The PROACT Trial
|
Mar 05, 2025 |
|
The ORBITA-COSMIC Trial
|
Feb 10, 2025 |
|
The REVIVED-BCIS2 Randomized Trial
|
Feb 04, 2025 |
|
Ketogenic Diet and Cardiovascular Risk
|
Jan 15, 2025 |
|
The CLEAR Outcomes Trial
|
Jan 08, 2025 |
|
Inflammatory Risk in Statin-Treated Patients
|
Dec 11, 2024 |
|
The BUDAPEST CRT Upgrade Trial
|
Dec 04, 2024 |
|
The HEART-FID Trial
|
Nov 20, 2024 |
|
The FIRE Study
|
Nov 06, 2024 |
|
The ECLS-SHOCK Trial
|
Oct 23, 2024 |
|
The STOPDAPT-3 Trial
|
Oct 09, 2024 |
|
The ILUMIEN IV Trial
|
Oct 02, 2024 |
|
OCT vs IVUS vs Angiography: A Meta-analysis
|
Sep 11, 2024 |
|
The ATTRibute-CM Trial
|
Sep 04, 2024 |
|
The ADVENT Trial
|
Aug 14, 2024 |
|
The ARAMIS Trial
|
Aug 07, 2024 |
|
The NITRATE-CIN Trial
|
Jul 31, 2024 |
|
The DICTATE-AHF Trial
|
Jul 10, 2024 |
|
The RIGHT Trial
|
Jul 03, 2024 |
|
Four-Year Results: The EVOLUT Low Risk Trial
|
Jun 12, 2024 |
|
The AGENT IDE Trial
|
Jun 05, 2024 |
|
The TRISCEND II Trial
|
May 22, 2024 |
|
The VIVA Trial
|
May 15, 2024 |
|
The SELECT Trial
|
May 01, 2024 |
|
The MINT Trial
|
Apr 17, 2024 |
|
The ORBITA-2 Trial
|
Apr 03, 2024 |
|
The ARIE-HM3 Trial
|
Mar 14, 2024 |
|
The AZALEA - TIMI Trial
|
Mar 11, 2024 |
|
The heart-1 Trial of VERVE-101
|
Feb 21, 2024 |
|
Lepodisiran Phase I Trial
|
Feb 07, 2024 |
|
CLEAR Outcomes Subanalysis
|
Jan 24, 2024 |
|
The AXIOMATIC - SSP Trial
|
Jan 10, 2024 |
|
The EBRAVE - AF Trial
|
Jan 03, 2024 |
|
The INVICTUS Trial
|
Dec 07, 2023 |
|
The FRAME-AMI Trial
|
Oct 04, 2023 |
|
MASTER DAPT: Long-Term Results
|
Sep 13, 2023 |
|
Episode 180: The PANTHER Trial
|
Sep 06, 2023 |
|
Radial vs. Femoral Access for PCI: Meta-Analysis
|
Aug 24, 2023 |
|
Episode 181: ACT Outpatient and Inpatient Trials
|
Aug 09, 2023 |
|
Episode 180: The VALOR-HCM Trial
|
Aug 02, 2023 |
|
Episode 179: The SODIUM-HF Study
|
Jul 12, 2023 |
|
Episode 178: The COMPLETE Trial
|
Jul 05, 2023 |
|
Episode 177: The EDIT-CMD Trial
|
Jun 14, 2023 |
|
Episode 176: The IVVE Trial
|
May 24, 2023 |
|
Episode 175: The METEORIC-HF Trial
|
May 17, 2023 |
|
Episode 174: The DIAMOND Trial
|
May 03, 2023 |
|
Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort
|
Apr 19, 2023 |
|
Episode 172:The PACIFIC-AF Study
|
Apr 05, 2023 |
|
Episode 171: The PROTECT Trial
|
Mar 22, 2023 |
|
Episode 170: The ADAPT-TAVR Trial
|
Mar 08, 2023 |
|
Episode 169: The FLAVOUR Trial
|
Mar 01, 2023 |
|
Episode 168: The GIPS-IV Study
|
Feb 08, 2023 |
|
Episode 167: The Spyral HTN-ON MED Pilot Study
|
Feb 01, 2023 |
|
Episode 166: Chronic Kidney Disease In CANTOS
|
Jan 11, 2023 |
|
Episode 165: The STAR-T/D Trial
|
Jan 04, 2023 |
|
Episode 164: The LOOP Study for AF Screening
|
Dec 14, 2022 |
|
Episode 163: The ENVISAGE-TAVI AF Trial
|
Dec 07, 2022 |
|
Episode 162: The FIGARO-DKD Trial
|
Nov 23, 2022 |
|
Episode 161: AMULET-IDE: One-Year Outcomes
|
Nov 09, 2022 |
|
Episode 160: Shock Classification Gets an Update
|
Nov 02, 2022 |
|
Episode 159: MICHELLE: Rivaroxaban in COVID-19
|
Oct 19, 2022 |
|
Episode 158: The RIPCORD 2 Trial
|
Oct 05, 2022 |
|
Episode 157: PARTNER 3: Two-Year Economic Outcomes
|
Sep 14, 2022 |
|
Episode 156: The IAMI Trial
|
Sep 07, 2022 |
|
Episode 155: Two DCBs Go Head to Head in De Novo CAD
|
Aug 25, 2022 |
|
Episode 154: The EMPEROR-Preserved Trial
|
Aug 10, 2022 |
|
Episode 153: iFR-SWEDEHEART at 5 Years
|
Aug 03, 2022 |
|
Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD
|
Jul 20, 2022 |
|
Episode 151: Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk
|
Jul 06, 2022 |
|
Episode 150: The TOMAHAWK Trial
|
Jul 06, 2022 |
|
Episode 149: The OPTIMUM Trial
|
Jun 22, 2022 |
|
Episode 148: The MASTER DAPT Trial
|
Jun 08, 2022 |
|
Episode 147: The EROSION III Trial
|
Jun 01, 2022 |
|
Episode 146: The LIFE Trial
|
May 18, 2022 |
|
Episode 145: PRAGUE 17: LAA Closure vs DOACs
|
May 04, 2022 |
|
Episode 144: MASTER DAPT: High-Risk Patients
|
Apr 20, 2022 |
|
Episode 143: The ADAPTABLE Study: Patient-Centered Aspirin
|
Apr 06, 2022 |
|
Episode 142: ISCHEMIA: Complete Revascularization and QoL
|
Mar 23, 2022 |
|
Episode 141: The STRENGTH Study of Omega-3s
|
Mar 16, 2022 |
|
Episode 140: The SWISS-APERO Trial
|
Mar 02, 2022 |
|
Episode 139: The 2021 ESC HF Guidelines
|
Feb 09, 2022 |
|
Episode 138: The ATLANTIS Trial: DOACs in TAVI?
|
Feb 02, 2022 |
|
Episode 137: Early Intrepid TMVR Results
|
Jan 12, 2022 |
|
Episode 136: Two DCBs vs POBA in Coronary In-Stent Restenosis
|
Jan 05, 2022 |
|
Episode 135: The ULTIMATE Trial
|
Dec 22, 2021 |
|
Episode 134: The PROSPECT ABSORB Trial
|
Dec 08, 2021 |
|
Episode 133: The COBRA-REDUCE Trial
|
Dec 02, 2021 |
|
Episode 132: The RIVER Trial
|
Nov 10, 2021 |
|
Episode 131: The SCOPE II Trial
|
Nov 03, 2021 |
|
Episode 130: The DISRUPT CAD III Trial
|
Oct 20, 2021 |
|
Episode 129: The TICO-STEMI Trial
|
Oct 06, 2021 |
|
Episode 128: The COMPARE CRUSH Trial
|
Sep 22, 2021 |
|
Episode 127: The SOLOIST-WHF and SCORED Trials
|
Sep 08, 2021 |
|
Episode 126: The REFLECT II Trial
|
Aug 25, 2021 |
|
Episode 125: The TIPS-3 Trial
|
Aug 18, 2021 |
|
Episode 124: The MITHRAS Trial
|
Aug 04, 2021 |
|
Episode 123: The XIENCE 90/28 Trial
|
Jul 21, 2021 |
|
Episode 122: The MSTOPS Trial
|
Jul 07, 2021 |
|
Episode 121: The TARGET FFR Trial
|
Jun 23, 2021 |
|
Episode 120: The STRENGTH Trial
|
Jun 16, 2021 |
|
Episode 119: The STRENGTH Trial
|
Jun 02, 2021 |
|
Episode 118: The OPTIMIZE Trial
|
May 19, 2021 |
|
Episode 117: The AHA COVID-19 CVD Registry
|
May 06, 2021 |
|
Episode 116: The TANGO Trial
|
Apr 21, 2021 |
|
Episode 115: The GALACTIC-HF Trial
|
Apr 07, 2021 |
|
Episode 114: The NACMI COVID-19 Registry
|
Mar 24, 2021 |
|
Episode 113: The EXPLORER-HCM Trial
|
Mar 17, 2021 |
|
Episode 112: FLASH Registry: Acute Hemodynamic Improvement
|
Mar 03, 2021 |
|
Episode 111: The PARALLAX Trial
|
Feb 17, 2021 |
|
Episode 110: The HOME-PE Trial
|
Feb 03, 2021 |
|
Episode 109: The EAST-AFNET 4 Trial
|
Jan 20, 2021 |
|
Episode 108: The BPLTTC Trial
|
Jan 06, 2021 |
|
Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease
|
Dec 16, 2020 |
|
Episode 106: TCT Connect 2020
|
Dec 02, 2020 |
|
Episode 105: POPULAR TAVI
|
Nov 04, 2020 |
|
Episode 104: EMPEROR Reduced
|
Oct 21, 2020 |
|
Episode 103: New ESC NSTEMI Guidelines
|
Oct 07, 2020 |
|
Episode 102: Innovation in Mitral Valve Repair
|
Sep 02, 2020 |
|
Episode 101: PARTNER 2A: 5-Year Outcomes
|
Aug 19, 2020 |
|
Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3
|
Aug 05, 2020 |
|
Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients
|
Jul 22, 2020 |
|
Episode 98: #WomenAs1: The Battle for Gender Equality
|
Jul 15, 2020 |
|
Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin
|
Jul 02, 2020 |
|
Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI
|
Jun 17, 2020 |
|
Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve
|
May 20, 2020 |
|
Episode 94: Wearables - The Future Is Now
|
Apr 22, 2020 |
|
Episode 93: Onyx ONE
|
Apr 17, 2020 |
|
Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin
|
Apr 01, 2020 |
|
Episode 91: Propensity Score-Matched Analysis
|
Mar 18, 2020 |
|
Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk
|
Mar 04, 2020 |
|
Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US
|
Feb 24, 2020 |
|
Episode 86: REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided Hydration
|
Jan 16, 2020 |
|
Episode 85: REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
|
Jan 07, 2020 |
|
Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI
|
Dec 18, 2019 |
|
Episode 83: The Medically Ill Patients in AUGUSTUS
|
Dec 04, 2019 |
|
Episode 82: EXCEL: 5-Year Outcomes
|
Nov 20, 2019 |
|
Episode 81: COAPT 3-Year Outcomes
|
Nov 06, 2019 |
|
Episode 80: PARTNER 3 Low-Risk Computed Tomography Substudy
|
Oct 25, 2019 |
|
Episode 79: LEVANT: 5-Year Outcomes From Three Randomized Trials
|
Oct 16, 2019 |
|
Episode 78: REDUCE-FMR: A Sham-Controlled Randomized Trial
|
Sep 18, 2019 |
|
Episode 77: PREPARE-CALC: High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation
|
Sep 04, 2019 |
|
Episode 76: Annapoorna Kini: Clinician, Researcher, Educator, and App Developer
|
Aug 22, 2019 |
|
Episode 75: CorMicA: A Randomized Trial of Invasive Coronary Function Testing
|
Aug 07, 2019 |
|
Episode 74: Quality of Life in the COAPT Study
|
Jul 24, 2019 |
|
Episode 73: COMPARE ABSORB
|
Jul 17, 2019 |
|
Episode 72: NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valves
|
Jul 03, 2019 |
|
Episode 71: ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance
|
Jun 18, 2019 |
|
Episode 70: FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary Angiography
|
Jun 05, 2019 |
|
Episode 69: SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve Implantation
|
May 24, 2019 |
|
Episode 68: TALENT: A Randomized Trial
|
May 15, 2019 |
|
Episode 67: RESET: Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents
|
May 01, 2019 |
|
Episode 66: PORTICO I: One-Year Outcomes
|
Apr 17, 2019 |
|
Episode 65: SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose
|
Apr 03, 2019 |
|
Episode 64: Building a New Backbone Upon Which to Randomize Patients: PERT Registry
|
Mar 20, 2019 |
|
Episode 63: TRIVALVE: Evaluation of Edge-to-Edge Valve Repair
|
Mar 06, 2019 |
|
Episode 62: BIONYX: A Randomized Trial
|
Feb 20, 2019 |
|
Episode 61: ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent
|
Feb 06, 2019 |
|
Episode 60: What Do You Get When You Combine Twitter and a Textbook? Tweetbook
|
Jan 23, 2019 |
|
Episode 59: IMPERIAL: A Randomized Trial of Drug-Eluting Stents
|
Jan 09, 2019 |
|
Episode 58: 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI
|
Jan 02, 2019 |
|
Episode 47: INTREPID
|
Jun 07, 2018 |
|
Episode 46: DAPT-STEMI
|
May 18, 2018 |
|
Episode 34: TRACER
|
Jan 08, 2018 |
|
Episode 35: TENDYNE Trial
|
Jan 08, 2018 |
|
Episode 33: DKCRUSH-V Trial
|
Dec 06, 2017 |
|
Episode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities
|
Dec 06, 2017 |
|
Episode 32: COLOR
|
Nov 30, 2017 |
|
Episode 30: PARTNER 2 Quality of Life
|
Sep 20, 2017 |
|
Episode 29: ILLUMENATE US
|
Sep 06, 2017 |
|
Episode 28: The AMULET OBSERVATIONAL STUDY
|
Sep 06, 2017 |
|
Episode 27: The WATCHMAN US Postapproval Study
|
Aug 15, 2017 |
|
Episode 26: PARTNER 1 5-YEAR ECHO - Long-term Hemodynamic and Structural Outcomes
|
Aug 02, 2017 |